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Introduction: While the development of fistulae is a well-known complication of radiotherapy, such fistulae can often be challenging to 
manage.
Case Presentation: We describe the case of a 37 year old male who developed in succession a urethrocutaneous fistula to the thigh, 
a rectourethral fistula and a peritoneo-urethral fistula 35 years after radiotherapy for pediatric pelvic rhabdomyosarcoma. These 
complications were managed successfully after multiple surgical procedures.
Discussion: We subsequently discuss the different approaches currently employed for the management of radiation induced urinary 
fistulas and describe the rationale behind our approach towards their surgical management.
Keywords:Radiation Injuries; Rhabdomyosarcoma; Surgical Flaps; Urinary Diversion; Urinary Fistula
Implication for health policy/practice/research/medical education:
Radiotherapy related complications can present even decades after irradiation, hence they must always be kept as differential diagnoses in such patients. 
Management of radiation induced urinary fistulas must be decided on an individualized, case by case basis. To aid in decision making, studies are re-
quired to further stratify patients with radiation induced urinary fistulas according to individual patient characteristics.
Copyright © 2014, Nephrology and Urology Research Center; Published by Kowsar Corp. This is an open-access article distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
Rhabdomyosarcoma is the commonest soft tissue sar-
coma among infants and children, accounting for nearly 
50% of all cases. Rhabdomyosarcoma of the genitourinary 
tract accounts for approximately 20% of all cases, with an 
incidence of 0.5 to 0.7 per million children younger than 
15 years (1). The current standard of treatment for rhab-
domyosarcoma is a combination of chemotherapy with 
or without adjuvant radiotherapy and surgical excision. 
High-dose irradiation (50 to 55Gy) is necessary to ensure 
local tumor control in patients who are unable to un-
dergo complete surgical resection, even if concomitant 
multi-agent chemotherapy is given.
 Among the complications of pelvic radiation, develop-
ment of urinary tract fistulae is rare, with reported inci-
dence of rectourethral fistula varying from 0.2% (2) to 1% 
(3), There have been only 2 case reports of urethrocuta-
neous fistula following radiation (4, 5). Although some 
urinary fistulae heal with conservative management, sur-
gery is often necessary for definitive management.
2. Case Presentation
A 37 year old male and current smoker (1 pack per day) 
with a history of prostate rhabdomyosarcoma at age 2 
treated with partial resection and high dose external 
beam radiation presented to the emergency department 
(ED) with fever, groin pain and abdominal distension. His 
history was notable for numerous complications includ-
ing bilateral osteonecrosis of the hip, lifelong complete 
urinary incontinence, a dense rectal stricture causing 
chronic colonic dilation and critical lower extremity 
ischemia due to bilateral iliofemoral disease. He had un-
dergone 45 procedures to address these complications. 
He was initially managed conservatively for intestinal 
obstruction secondary to a rectal stricture. Rectal dila-
tion was performed. Subsequently, he developed MSSA 
(methicillin sensitive Staphylococcus aureus) bacteremia 
and an abscess was noted in his left thigh (adductor re-
gion). The abscess was drained under ultrasound guid-
ance by the interventional radiology team, and the drain 
was removed after a week. A month later, he presented to 
the ED with fluid draining from the former site of the IR 
drain. The fluid was found to be urine, with creatinine of 
30.9 mg/dL. A Foley catheter was placed, and retrograde 
urethrogram (RUG) showed a urethrocutaneous fistula 
from the bulbar urethra to the left thigh (Figure 1). Cys-
toscopy and subsequent biopsy of the fistula revealed 
no malignancy. Given the need of serial rectal dilations 
for his chronically dilated large bowel, the patient was 
formally recommended a permanent colostomy, but he 
declined. He was discharged with catheter in place and 
the fistula site dry.
As definitive treatment for the fistula, an ileal conduit 
urinary diversion with partial cystectomy was done. The 
patient was discharged postoperatively on day 12, with Sharma A et al.
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fistula dry and scant discharge per urethra. Two months 
after this surgery, the patient developed a cold lower limb 
for which he underwent a successful axillary-femoral ar-
tery graft thrombectomy. The next month, he also under-
went a major hip joint reconstruction. 8 weeks later, he 
developed fever and chills followed by passage of feces 
per urethra. The next week, he developed fecal drainage 
from the left thigh as well. A RUG was performed and re-
vealed a rectourethral fistula (Figure 2). To treat this rec-
tourethral fistula an end colostomy with distal mucus fis-
tula was performed. Drainage from the urethra and thigh 
fistula persisted despite the surgery. Proctoscopy showed 
a tight rectal stricture at 8 cm. Colonic irrigation through 
a red rubber tube, passed through the distal mucus limb 
of his colostomy was done with the aim of clearing out 
the stool in his distal colon from his thigh fistula.
The cutaneous fistula remained dry for several weeks. 
Leakage per rectum remained minimal. He then re-
ported passage of sutures per urethra and discharge of 
straw-colored peritoneal fluid from both the urethra 
and thigh fistulae. As a temporary measure, he under-
went intraoperative cystoscopic identification of the 
fistula site and urethral bulking therapy using a dextra-
nomer and hyaluronic acid (Deflux®, Salix Pharmaceu-
ticals, Raleigh) applied to the fistula site. Debridement 
of the left groin fistula tract, and negative pressure 
wound therapy placement to control drainage from the 
peritoneo-urethral fistula was also done. Postoperative-
ly, the drainage from the thigh and urethra persisted, 
so he underwent takedown of the previous descending 
colostomy and mucus fistula, descending colectomy 
and proctectomy, creation of a new permanent colos-
tomy and simple cystectomy. As drainage still persisted 
after this, his urethra was closed perineally proximal to 
the fistula, and the defect was reinforced with a pedi-
cled rectus femoris muscular flap. His incisions have 
healed well, and he no longer has drainage 5 months 
after surgery.
Figure 1. Retrograde Urethrogram Performed After Patient Developed 
Leakage of Urine From Left Thigh
a) Leakage of contrast from bulbar urethra, b) Urethrocutaneous fistula 
from urethra to left thigh demarcated with contrast
Figure 2. Retrograde Urethrogram Performed After Patient Developed 
Leakage of Stool From Left Thigh
a) Leakage of contrast from urinary tract into the rectum, b) Rectoure-
thral fistula (encircled) demarcated with contrastSharma A et al.
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3. Discussion
This case is an example of late-onset radiation injury, 
with rectal and genitourinary complications 35 years af-
ter radiation. Radiation-induced fibrosis is the hallmark 
of such injury. Acute inflammation at the time of radia-
tion initiates a fibrogenic cascade similar to that seen in 
normal tissue injury and scarring. The resultant fibro-
genic response is mediated by several cytokines espe-
cially TGF-beta, PDGF, and IL-13. This fibrogenic cascade is 
dysregulated and altered in irradiated tissues, resulting 
in pathological fibrosis and its complications including 
strictures and fistulae (6, 7). Risk factors such as cigarette 
smoking, race, and increased body mass index have been 
associated with major late complications of the bladder, 
rectum and small bowel following pelvic radiation (8, 9). 
Though long considered irreversible, promising thera-
pies using agents such as pentoxifylline, vitamin E, clo-
dronate, superoxide dismutase and hyperbaric oxygen 
have begun to show that radiation-induced fibrosis may 
be preventable and reversible (10-12).
The debate on whether a radiation induced fistula de-
serves an attempt at repair or be dealt aggressively with 
permanent diversion surgeries from the start is presently 
unsettled. In their study, Linder et al. (13) advocate that per-
manent urinary diversion with our without permanent 
colostomy should be considered early in the surgical man-
agement of these patients. They reported that primary re-
pair was successful in only 1 out of 6 patients with radiation 
induced fistulas in whom primary repair was attempted, 
compared to successful repair in 15 out of 16 patients with 
fistulas due to other causes. A vast majority of patients 
with radiation induced fistulas required permanent colos-
tomy (25/29), or permanent urinary diversion (27/29). On 
the other hand, Lane et al. (14) report in their study that 
out 18 patients with radiation induced rectourethral fistu-
las taken up for definitive surgery, successful fistula repair 
was performed without any form of permanent diversion 
in 8 patients ,and repair with preservation of at least one 
sphincter was performed in 5 patients. Combined fecal 
and urinary diversion was required only in 5 patients. Suc-
cessful fistula repairs in the setting of radiation have also 
been reported by Voelzke et al. (15) ( n = 13, 8 successful), 
Vanni et al. (16) (n = 39, 84% repaired in single stage), Lesser 
et al. (17) and Iachetta et al. (18).
The term 'Radiation Induced Fistula' is a blanket term, 
encompassing a heterogeneous group of patients having 
diverse variations in fistula anatomy, pre-morbid urinary 
and bowel function, health of surrounding tissues, pres-
ence of co-morbidities, life expectancy, and severity of 
radiation exposure Each of these factors can affect surgi-
cal outcomes. Thus, creating and defining treatment pro-
tocols based upon superficial categories like 'radiation 
induced' vs. 'non radiation induced' types of fistulas is 
unlikely to provide optimum decisions for patients.
Therefore, we stress upon the need to approach such 
patients on a highly individualized, case by case basis, 
giving due importance to individual factors and patient 
preferences. Initial management of radiation induced 
urinary fistulae involves urinary and/or fecal diversion. 
Further definitive management of the fistula should be 
decided on the basis of patient factors such as life ex-
pectancy, pre-morbid urinary and bowel function, con-
tinence, local anatomy and the technical feasibility of a 
repair (14). Thus, cystoprostatectomy and ileal conduit 
urinary diversion is appropriate in a patient lacking 
bladder control, whereas a continent patient would ben-
efit from a urethral repair along with muscle/omentum 
interposition. Likewise, pre-operative fecal continence 
would influence the choice between a primary bowel 
repair or a proctocolectomy and permanent colostomy. 
Of prime importance is the patient’s personal prefer-
ence, and the risks and benefits of diversion versus repair 
should be extensively discussed with the patient to assist 
them in making an appropriate decision.
Our patient, apart from his urethral fistulas, was also 
suffering from several other co-morbidities which were 
of great concern to him, including an extremely painful 
hip joint that needed reconstruction. He had already un-
dergone 45 major surgical procedures to repair his pelvic 
and inguinal vasculature and his hip joints. The absence 
of urinary continence since childhood, and the need for 
total clearance of infection from the surrounding tis-
sues in order to allow the patient to proceed for an or-
thopedic hip reconstruction also favored in the decision 
to perform permanent ileal conduit urinary diversion. 
The patient declined to undergo permanent colostomy 
as treatment for his rectal strictures. To treat the recto-
urethral fistula that subsequently developed temporary 
fecal diversion was performed. An end colostomy with 
distal mucus fistula was preferred over a simple loop co-
lostomy since his descending colon was dilated to such 
an extent that a loop colostomy would have required a 
very large abdominal stoma, with its inherent complica-
tions. As this too failed to control discharge, permanent 
colostomy, with complete cystectomy was finally agreed 
upon and performed.
Given the inability of the tissues to hold sutures which 
resulted in the peritoneo-urethral fistula, urethral bulk-
ing using Deflux™ (a Dextranomer and Hyaluronic Acid 
polymer) was done. It was extensively discussed with the 
patient that while urethral bulking could diminish the 
flow, but it was not expected to provide definitive cure, 
and could be thought of as the first step of the reconstruc-
tive process. One of the indications for urethral bulking 
therapy is incontinence associated with late radiation ef-
fects on the bladder and urethra. These cases involve ra-
diation-induced detrusor are flexia, poor bladder compli-
ance, moderate residual urine, constant urinary leakage 
and a rigid, open, nonfunctional urethra. Open surgery 
will not cure such incontinence, and might elevate the 
detrusor leak-point pressure and cause upper-tract dis-Sharma A et al.
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ease. Bulking agents do not change detrusor leak-point 
pressures and are, therefore, safer in these circumstances 
(19, 20). Complete control of the peritoneo-urethral fis-
tula was obtained by closing down his urethra perineally 
proximal to the fistula, and the reinforcement of the de-
fect with a pedicled rectus femoris muscular flap.
Radiotherapy related complications should always be 
kept in mind while treating patients with a past history 
of radiation, as shown in this case where urological com-
plications started 35 years after pelvic radiation. Individ-
ual factors must be taken into account while making the 
decision between permanent urinary/fecal diversion and 
definitive repair. Since attempts at repair in such cases 
carry a substantial risk of failure and need for repeat sur-
geries, there is need for studies to further stratify such 
patients according to their individual characteristics. 
Surgical management of urinary fistulae in the setting of 
radiation should be approached on a case by case basis, 
because repair may involve innovative or improvisation-
al maneuvers in the operating room.
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